In a mixed Q2 financial report, Mindray Medical, a major China medical device company, reported higher numbers for the period, though revenues were below analysts’ predictions. The company blamed the miss on a decline in its Q2 China revenues, largely because of a shortfall in its revenues from government tenders. International sales, on the other hand, remained robust, rising 27%. More details...

Stock Symbol: (NYSE: MR)